| |
Patients with TEs N: 10
|
Patients without TEs N: 125
|
P value
|
Patients with bleeding events N: 12
|
Patients without bleeding events N: 123
|
P value
|
|---|
|
Age, years
|
49.3 ± 13.8
|
51.7 ± 13.7
|
0.600
|
48.0 ± 9.1
|
51.8 ± 14.1
|
0.356
|
|
Gender, male (%)
|
4 (40.0)
|
45 (36.0)
|
1.0
|
4 (33.3)
|
45 (36.6)
|
1.0
|
|
Atrial fibrillation, n (%)
|
8 (80)
|
63 (50.4)
|
0.101
|
7 (58.3)
|
64 (52)
|
0,768
|
|
Hypertension, n (%)
|
5 (50)
|
44 (35.2)
|
0.496
|
4 (33.3)
|
45 (36.6)
|
1.0
|
|
Diabetes mellitus, n (%)
|
0
|
17 (13.6)
|
0.361
|
1 (8.3)
|
16 (13)
|
1.0
|
|
Smoking, n (%)
|
3 (37.5)
|
28 (24.6)
|
0.418
|
4 (33.3)
|
27 (24.5)
|
0.498
|
|
Neurological dysfunction, n (%)
|
2 (20)
|
6 (4.8)
|
0.109
|
3 (25)
|
5 (4.1)
|
0.024
|
|
Follow-up Time, months
|
47.1 ± 30.7
|
39.0 ± 30.5
|
0.439
|
53.2 ± 39.4
|
38.3 ± 30.4
|
0.117
|
|
Mean LVEF, %
|
55.9 ± 10.2
|
53.9 ± 9.1
|
0.514
|
54.0 ± 12.9
|
54.0 ± 8.9
|
0.984
|
|
Left Atrium, cm
|
5.6 ± 1.1
|
5.5 ± 1.0
|
0.799
|
5.7 ± 0.9
|
5.5 ± 1.0
|
0.642
|
|
sPAP, mmHg
|
44.1 ± 12.9
|
42.3 ± 13.5
|
0.692
|
41.9 ± 12.5
|
42.5 ± 13.5
|
0.881
|
|
Hemoglobin, g/dL
|
12.7 ± 1.1
|
13.0 ± 1.6
|
0.512
|
13.2 ± 1.4
|
13.0 ± 1.7
|
0.587
|
|
Platelet, ×103/μL
|
211 ± 63
|
218 ± 77
|
0.769
|
259 ± 57
|
214 ± 76
|
0.051
|
|
Creatinine, mg/dL
|
0.8 ± 0.2
|
1.2 ± 1.2
|
0.283
|
0.9 ± 0.2
|
1.2 ± 1.2
|
0.457
|
|
Mean INR level
|
2.1 ± 0.4
|
2.4 ± 0.5
|
0.022
|
2.4 ± 0.4
|
2.7 ± 0.5
|
0.016
|
- INR: International Normalized Ratio, LVEF: Left Ventricle Ejection Fraction, sPAP: Systolic Pulmonary Arterial Pressure, TEs: Thromboembolic events.
- Data are presented as number (percentage) and mean ± SD values.
- Chi-square, unpaired Student-t test and the Mann–Whitney U test.
